Boucherville, QC, June 21, 2016 – Sandoz Canada announces the launch of S.O.S. Naloxone™ Hydrochloride Injection on the Canadian market. It is the first non-prescription medicine to have been approved by Health Canada for the emergency treatment of opioid-related overdose. Prior to the launch of this new product, naloxone had been sold by prescription only for more than 20 years. This prescription product remains available.
